These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6175122)

  • 1. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
    Baranowska B; Kuzaka B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treating prostatic adenoma with Depostat].
    Darenkov AF; Zakhvatov IuM; Tanko A; Ignashin NS; Varentsov GI
    Urol Nefrol (Mosk); 1980; (5):34-7. PubMed ID: 6158780
    [No Abstract]   [Full Text] [Related]  

  • 4. Conservative treatment of benign prostatic hyperplasia.
    Palanca E; Juco W
    Curr Med Res Opin; 1977; 4(7):513-20. PubMed ID: 66118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical therapy of benign prostatic hyperplasia: cyproterone acetate vs gestonorone caproate].
    Di Silverio F
    Minerva Urol Nefrol; 1986; 38(2):163-71. PubMed ID: 2428120
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Depostat in prostatic adenoma on the ground of clinical and sphincterotonometric studies.
    Makrigiannis D; Gaca A
    Int Urol Nephrol; 1971; 3(1):21-9. PubMed ID: 4117491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monitoring the effectiveness of conservative treatment of benign prostatic hypertrophy by means of uroflowmetry].
    Tunn U; Senge T
    Z Urol Nephrol; 1978 Aug; 71(8):521-8. PubMed ID: 83057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depostat for benign prostatic hyperplasia?
    Drug Ther Bull; 1973 Sep; 11(19):75-6. PubMed ID: 4130364
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrinological principles of conservative therapy for prostatic adenoma].
    Altwein JE; Orestano F
    Dtsch Med Wochenschr; 1975 Mar; 100(12):626-9. PubMed ID: 47287
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and urodynamic evaluation of efficacy of conservative treatment of urination disorders in patients with benign prostate hyperplasia].
    Danilov VV; Danilova TI; Danilov VV; Danilov VV
    Urologiia; 2013; (5):55-8. PubMed ID: 24437242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
    Chen KK; Chang LS; Chen MT; Huang JK; Yin JH; Lin SN; Lin AD
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):127-30. PubMed ID: 2458811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results].
    Kanimoto Y; Okada K
    Hinyokika Kiyo; 1991 Nov; 37(11):1423-8. PubMed ID: 1722627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia.
    Schulman CC; Lock TM; Buzelin JM; Boeminghaus F; Stephenson TP; Talja M;
    J Urol; 2001 Oct; 166(4):1358-63. PubMed ID: 11547074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
    Urologiia; 2005; (5):25-6. PubMed ID: 16281835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results.
    Chancellor MB; Atan A; Rivas DA; Watanabe T; Tai HL; Kumon H
    Tech Urol; 1999 Dec; 5(4):191-4. PubMed ID: 10591256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
    Maver A
    Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of benign enlargement of the prostate with nor progesterone caproate (primostat).
    Subbiah N; Mortensen J
    Aust N Z J Surg; 1973 Feb; 42(3):304-7. PubMed ID: 4129814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Several difficult diagnoses of dysuria in patients with prostatic adenoma: value of urodynamic studies].
    Le Normand L
    Prog Urol; 1999 Feb; 9(1):142-5. PubMed ID: 10212968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.